Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials

Neurol Ther. 2020 Jun;9(1):193-195. doi: 10.1007/s40120-020-00178-4.

¹ Centro Studi Sclerosi Multipla, Gallarate, Italy. [email protected].
² Partners Pediatric Multiple Sclerosis Centre, Massachusetts General Hospital, Boston, MA, USA.
³ Novartis Pharma AG, Basel, Switzerland.
⁴ DATAMAP GmbH, Freiburg, Germany.
⁵ Division of Neurology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

Abstract

Figures 1a, 1b and 3 were published incorrectly in the original version. The corrected images are given as follows.